Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Net Margin: 2020-2024

Historic Net Margin for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to 13.47%.

  • Oncology Institute's Net Margin rose 31500.0% to 10.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.62%, marking a year-over-year increase of 44200.0%. This contributed to the annual value of 13.47% for FY2024, which is 74600.0% up from last year.
  • As of FY2024, Oncology Institute's Net Margin stood at 13.47%, which was up 74600.0% from 20.93% recorded in FY2023.
  • In the past 5 years, Oncology Institute's Net Margin registered a high of 3.41% during FY2020, and its lowest value of 20.93% during FY2023.
  • For the 5-year period, Oncology Institute's Net Margin averaged around 9.96%, with its median value being 6.73% (2022).
  • Its Net Margin has fluctuated over the past 5 years, first crashed by -142100bps in 2023, then surged by 74600bps in 2024.
  • Over the past 5 years, Oncology Institute's Net Margin (Annual) stood at 3.41% in 2020, then tumbled by -53bps to 5.24% in 2021, then fell by -28bps to 6.73% in 2022, then plummeted by -211bps to 20.93% in 2023, then surged by 36bps to 13.47% in 2024.
  • Its last three reported values are 13.47% in FY2024, 20.93% for FY2023, and 6.73% during FY2022.